A comparative study of immunohistochemical and chromogenic in situ hybridization (CISH) evaluation of HER2 status in breast cancer

被引：0
|
作者：
Lubomirova, Hristova S. [1 ]
Vlahova, I. A. [1 ]
Iliichev, Dikov T. [1 ]
机构：
[1] Med Univ Sofia, Sofia, Bulgaria
来源：
VIRCHOWS ARCHIV | 2009年 / 455卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [41] Chromogenic in situ hybridization (CISH):: a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status
    Madrid, MA
    Lo, RW
    BREAST CANCER RESEARCH, 2004, 6 (05): : R593 - R600
  • [42] Chromogenic in situ hybridization (CISH) is a reliable method for detecting HER-2 gene status in breast cancer: A multicenter study comparing three methods
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Fang, Y.
    Zhao, J.
    Tarco, E.
    Symmans, W. F.
    Isolo, J.
    Sneige, N.
    LABORATORY INVESTIGATION, 2008, 88 : 33A - 33A
  • [43] Chromogenic in situ hybridization (CISH) is a reliable method for detecting HER-2 gene status in breast cancer: A Multicenter study comparing three methods
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Fang, Y.
    Zhao, J.
    Tarco, E.
    Symmans, W. F.
    Isola, J.
    Sneige, N.
    MODERN PATHOLOGY, 2008, 21 : 33A - 33A
  • [44] Reliability of Chromogenic In Situ Hybridization (CISH) for Detecting HER2 Gene Status in Breast Cancer: A Study of Two Institutions Using Manufacturers' Scoring Criteria and the New ASCO/CAP Recommendations
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Zhao, J.
    Tarco, E.
    Symmans, W. F.
    Isola, J.
    Sneige, N.
    LABORATORY INVESTIGATION, 2009, 89 : 43A - 43A
  • [45] Reliability of Chromogenic In Situ Hybridization (CISH) for Detecting HER2 Gene Status in Breast Cancer: A Study of Two Institutions Using Manufacturers' Scoring Criteria and the New ASCO/CAP Recommendations
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Zhao, J.
    Tarco, E.
    Symmans, W. F.
    Isola, J.
    Sneige, N.
    MODERN PATHOLOGY, 2009, 22 : 43A - 43A
  • [46] Characterisation of HER2 Status in DCIS Using Immunohistochemistry (IHC) and Chromogenic in situ Hybridisation (CISH)
    Miligy, I.
    Gaber, A.
    Toss, M. S.
    Al-Kawaz, A. A.
    Nolan, C. C.
    Diez-Rodriguez, M. A.
    Burrell, H.
    Ellis, I. O.
    Green, A. R.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2018, 245 : S5 - S5
  • [47] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Nie, Xiu
    He, Jun
    Li, Yan
    Pan, Dan-zhen
    Pan, Hua-xiong
    Weng, Mi-xia
    Yang, Xiu-ping
    Liu, Chun-ping
    Huang, Tao
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (03) : 379 - 384
  • [48] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Xiu Nie
    Jun He
    Yan Li
    Dan-zhen Pan
    Hua-xiong Pan
    Mi-xia Weng
    Xiu-ping Yang
    Chun-ping Liu
    Tao Huang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 379 - 384
  • [49] Accurate Assessment of HER2 Gene Status for Invasive Component of Breast Cancer by Combination of Immunohistochemistry and Chromogenic In Situ Hybridization
    聂秀
    贺骏
    李燕
    潘丹珍
    潘华雄
    翁密霞
    杨秀萍
    刘春萍
    黄韬
    Current Medical Science, 2013, (03) : 379 - 384
  • [50] HER-2 NEU in breast cancer patients.: Immunohistochemical comparison with mono and polyclonal antibodies.: Amplification with Chromogenic in Situ Hybridization (CISH)
    Perez, M. I.
    Picon, G.
    Ugalde, J.
    PROCEEDINGS OF THE 3RD INTERCONTINENTAL CONGRESS OF PATHOLOGY - FREE PAPERS, 2008, : 177 - 181
12345